YURTDAŞ KIRIMLIOĞLU, G. Et Al. 2022. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay. MICROVASCULAR RESEARCH , vol.139 .

YURTDAŞ KIRIMLIOĞLU, G., Gulec, K., Gorgulu, S., & KIYAN, H. T., (2022). Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay. MICROVASCULAR RESEARCH , vol.139.

YURTDAŞ KIRIMLIOĞLU, GÜLSEL Et Al. "Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay," MICROVASCULAR RESEARCH , vol.139, 2022

YURTDAŞ KIRIMLIOĞLU, GÜLSEL Y. Et Al. "Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay." MICROVASCULAR RESEARCH , vol.139, 2022

YURTDAŞ KIRIMLIOĞLU, G. Et Al. (2022) . "Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay." MICROVASCULAR RESEARCH , vol.139.

@article{article, author={GÜLSEL YURTDAŞ KIRIMLIOĞLU Et Al. }, title={Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay}, journal={MICROVASCULAR RESEARCH}, year=2022}